Does a positive NECPAL score mean higher risk of dying for ICU patients aged 75 and older?
Is a Positive NECPAL in ICU Patients Associated With Higher Mortality
This project will test if a positive NECPAL score can identify ICU patients aged 75 or older who have a higher chance of dying within 90 days of admission.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 199 (estimated) |
| Ages | 75 Years and up |
| Sex | All |
| Sponsor | Consorci Sanitari de l'Alt Penedès i Garraf Academic / other |
| Locations | 1 site (Sant Pere de Ribes, Barcelona) |
| Trial ID | NCT07007156 on ClinicalTrials.gov |
What this trial studies
This observational study will enroll patients aged 75 and older admitted to the ICU at CSAPG in Sant Pere de Ribes, Barcelona. At enrollment clinicians will record the NECPAL score and baseline clinical information without changing usual care. Participants will be followed for 90 days after ICU admission to capture mortality outcomes, excluding patients who die within the first 24 hours. The analysis will compare 90-day mortality between patients with a positive NECPAL and those without to see if the score predicts higher risk.
Who should consider this trial
Good fit: Ideal candidates are ICU patients aged 75 or older admitted to the CSAPG center who can provide informed consent or have a legal representative sign consent.
Not a fit: Patients under 75, those not admitted to the CSAPG ICU, or those who die within the first 24 hours are unlikely to gain benefit from this observational test.
Why it matters
Potential benefit: If successful, clinicians could use NECPAL to identify older ICU patients at higher 90-day mortality risk and prioritize palliative care conversations and care planning.
How similar studies have performed: NECPAL has shown promise in other clinical populations for identifying palliative needs and predicting mortality, but its performance specifically in ICU settings is less well established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who meet all of the following inclusion criteria may be included in the study: * Men and women aged 75 years or older. * Admission to the ICU of the study center. * Legal capacity to provide informed consent. * Signed informed consent for study inclusion, either by the participant or their legal representative. Exclusion Criteria: Participants who meet any of the following exclusion criteria may not be included in the study: -Death within the first 24 hours of ICU admission.
Where this trial is running
Sant Pere de Ribes, Barcelona
- Csapg — Sant Pere de Ribes, Barcelona, Spain (Recruiting)
Study contacts
- Principal investigator: Diana Gutiérrez, MD — Csapg
- Study coordinator: Diana Gutiérrez, MD
- Email: dpgutierrez@csapg.cat
- Phone: +34938960025
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.